Antonia DePace

Some patients with MPN in the UK were not prescribed the correct medications for management of specific diseases, highlighting the need for improvements in cardiovascular and thrombotic risk management.

Even with newer technologies such as mRNA, experts predict it will be a few years before another cancer vaccine is approved.

Novel combo regimen reduces number of toxic treatments in patients with NSCLC.

Experts urge patients to stop playing the wait-and-see game: There’s no ‘playbook’ for immunotherapy-related toxicities, and side effects can be managed if caught early.

To avoid the financial burden of costly therapies, patients with cancer receiving immunotherapy treatments should talk with their health care team and not settle for no as an answer from their health insurance provider, according to an expert.

Cirmtuzumab plus Imbruvica led to an 83.3% overall response rate, with 38.9% complete response and 44.4% partial response rate, in patients with mantle cell lymphoma and chronic lymphocytic leukemia.

More than half of patients with previously treated advanced colorectal cancer who were treated with Lenvima and Keytruda were alive at six months while maintaining a manageable safety profile.

Lifileucel with Keytruda may lead to an improved overall response rate of 86% for patients with advanced melanoma who were pre-checkpoint inhibitor naïve compared with those treated with Keytruda alone.

The study results, according to the authors, suggest that the combination of folinic acid plus the chemotherapies fluorouracil and oxaliplatin should become the standard-of-care therapy in patients with advanced biliary tract cancer whose disease progressed with cisplatin and gemcitabine.

The effectiveness of the Pfizer-BioNTech COVID-19 vaccine increased significantly among patients with cancer who received a vaccine booster 21 days after receiving the first dose.

Long-term survivors of childhood cancer may have increased risks of cancer-related worries, which may be associated with higher levels of substance use, health care utilization and lower rates of physical activity.

Recently published data support the use of next-generation sequencing as a standard practice in patients with advanced cancer and cancer of an unknown primary location, according to the study’s authors.

Several factors including female sex, lower socioeconomic status and high intensity surgery were associated with a higher risk of moderate-to-severe symptoms in older adults with cancer following surgery.

While it may not be the first thing patients think of when diagnosed with cancer, appropriate clothing centered around treatment can help ease their overall experience, according to an expert.

Childhood cancer survivors are at a higher risk of pain and associated functional impairments later in life, study results show. These results, according to experts, highlight the need for routine pain screening in survivors.

The biggest fear for many patients, according to an expert from The University of Texas MD Anderson Cancer Center, is when they hear that myeloma, for most patients, is not curable. However, she notes that every few years patient survival is increasing.

The FDA recently approved an expanded indication for Lorbrena as a first-line treatment option for a subset of lung cancer that has spread to the brain. Compared to previously-approved options, experts say Lorbrena is more effective.

With a limited number of COVID-19 vaccines available, the most important takeaway from the updated NCCN guidelines is that patients with cancer get a COVID-19 vaccine — no matter which one it is — according to an expert from the Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center.

Data from a recent study demonstrates that patients with breast cancer — especially those who are younger, privately insured, of non-White race and lower-income — are more likely to file for bankruptcy than those without cancer.

Of note, estimates show that there are more than 25,000 patients undergoing allogeneic hematopoietic cell transplantations throughout the United States and beyond. Recent study results show that these patients may be at a higher risk for de novo atrial fibrillation.

Increasing healthy eating habits and exercise is important in patients with breast cancer, according to an expert from Mass General Cancer Center.

Data from a recent study found that while the risk of developing cancer is 1.74 times greater for individuals born with major birth defects, that risk is highest in childhood but decreases slightly after age 20.

The National Comprehensive Cancer Network (NCCN) recently released the best practices for the management of COVID-19 infection in patients with cancer.

Having an exercise professional in chemotherapy infusion suites could significantly benefit patients with cancer and help improve health-related outcomes such as fatigue, according to recent study results.

The results, according to the study authors, should be reassuring to patients who may have been concerned about the risk of contracting the virus that causes COVID-19 from surfaces in cancer centers.